Hanne Jensen

Chief Operating Officer at CURASIGHT A/S

Net worth: 15 228 $ as of 29/04/2026

Health Technology

Consumer Services

Profile

Hanne Damgaard Jensen currently works at ROS-Therapeutics ApS, as Chief Executive Officer from 2018, Aimvion A, as Chairman from 2020, and Curasight A, as Chief Operating & Development Officer from 2022.
Ms. Jensen also formerly worked at Azanta A, as Chief Executive Officer from 2009 to 2017, Johnson & Johnson, as Principal, Novo Nordisk A, as Project Manager from 1995 to 1999, Genmab A, as Senior Vice President-Drug Development, and Roche Innovation Center Copenhagen A, as Senior Vice President-Product Development from 2007 to 2008.
Ms. Jensen received her Masters Business Admin degree from Copenhagen Business School, graduate degree from the University of Copenhagen, and Masters Business Admin degree from Scandinavian International Management Institute.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CURASIGHT A/S 0.01%	29/06/2025	6,929 ( 0.01% )	15 228 $	29/04/2026

Hanne Jensen active positions

Companies	Position	Start
CURASIGHT A/S	Chief Operating Officer	31/12/2021
ROS-Therapeutics ApS	Chief Executive Officer	31/12/2017
Aimvion A/S Aimvion A/S Pharmaceuticals: MajorHealth Technology Provides services for autoimmune diseases and biotechnology	Chairman	31/12/2019

All active positions of Hanne Jensen

Former positions of Hanne Jensen

Companies	Position	End
Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine	Chief Executive Officer	31/12/2016
Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases	Corporate Officer/Principal	31/12/2007
GENMAB A/S	Corporate Officer/Principal	-
NOVO NORDISK A/S	Corporate Officer/Principal	31/12/1998
JOHNSON & JOHNSON	Corporate Officer/Principal	-

See the detail of Hanne Jensen's experience

Training of Hanne Jensen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hanne Jensen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Genmab A/S Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines	Health Technology
Copenhagen Business School Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roche Innovation Center Copenhagen A/S Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Scandinavian International Management Institute Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine	Health Technology
Curasight A/S Curasight A/S Medical SpecialtiesHealth Technology Provides PET imaging research techniques for prostate cancer	Health Technology
Aimvion A/S Aimvion A/S Pharmaceuticals: MajorHealth Technology Provides services for autoimmune diseases and biotechnology	Health Technology
ROS-Therapeutics ApS